Recurrent B-cell non-Hodgkin lymphoma
Clinical trials for Recurrent B-cell non-Hodgkin lymphoma explained in plain language.
Never miss a new study
Get alerted when new Recurrent B-cell non-Hodgkin lymphoma trials appear
Sign up with your email to follow new studies for Recurrent B-cell non-Hodgkin lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo shows promise for Tough-to-Treat blood cancers
Disease control CompletedThis phase 2 trial tested the immunotherapy drug pembrolizumab (Keytruda) alone or combined with idelalisib or ibrutinib in 65 patients with chronic lymphocytic leukemia (CLL) or low-grade B-cell non-Hodgkin lymphoma (NHL) that had returned or stopped responding to treatment. The…
Matched conditions: RECURRENT B-CELL NON-HODGKIN LYMPHOMA
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental combo therapy shows promise for Tough-to-Treat lymphomas
Disease control CompletedThis phase 1/2 trial tested a new treatment for people with CD30-positive Hodgkin or non-Hodgkin lymphomas that returned or didn't respond to prior therapy. The treatment combines AFM13, an antibody that targets cancer cells, with natural killer (NK) cells from donated umbilical …
Matched conditions: RECURRENT B-CELL NON-HODGKIN LYMPHOMA
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC